Stay updated on Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T22:43:56.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study details of a phase II trial testing the combination of pembrolizumab and interferon gamma-1b for the treatment of mycosis fungoides, Sezary syndrome, and synovial sarcoma.
    Difference
    0.0%
    Check dated 2024-06-06T14:31:49.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying health conditions and prior treatments required for inclusion in the study. This change provides more specific information about the types of patients researchers are looking for, particularly those with Mycosis Fungoides or Sezary syndrome.
    Difference
    59%
    Check dated 2024-05-22T20:57:12.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-04-30T22:21:55.000Z thumbnail image

Stay in the know with updates to Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.